This Week in Psychedelics - 1.21.22

Cannabis

• Thailand Plans to Make Marijuana Legal, Scrapping Jail Terms and Fines for Possession (Bloomberg)

• U.S. Senate Candidate Smokes Marijuana Blunt In Campaign Ad About Harms Of Criminalization (Marijuana Moment)

• After One Year As President, Biden’s Marijuana Promises Remain Unfulfilled (Marijuana Moment)

• Mississippi House Approves Medical Marijuana Bill With Amendments (Marijuana Moment)

• It’s high time that people caught with cannabis be spared jail, declare public (The Telegraph)

• London’s Cannabis Diversion Plan Draws Political Fire (Filter)

• Kansas Medical Marijuana Hearings Cancelled After Senate GOP Leader Reroutes House-Passed Bill (Marijuana Moment)

• What Is THC-O Acetate, And Why Is It Getting Attention? (Forbes)

• Study Shows Cannabis was Food Staple for Ancient Chinese Dynasty (High Times)

• Most Americans Predict Biden Won’t Uphold Marijuana Decriminalization Promise In 2022, Poll Finds (Marijuana Moment)

• Austin, Texas Cannabis Decriminalization Initiative Set for Ballot in May (High Times)

• Rhode Island Governor Includes Marijuana Legalization And Expungements In Budget Request (Marijuana Moment)

• Cannabis use impacts cognitive ability beyond intoxication: study (CTV News)

• Minnesota Democratic Leaders Preview Marijuana Legalization Plan For 2022 (Marijuana Moment)

• Ohio Advocates Submit Additional Signatures for Cannabis Proposal (High Times)

• Kentucky Addresses Cannabis Reform Through New Legislation (High Times)

• Canada might be home to the world’s first airport dispensary (Leafly)

• Nebraska Activists Say New GOP Medical Marijuana Bill Is A ‘Poison Pill’ Meant To Detract From Ballot Efforts (Marijuana Moment)

• South Dakota Governor Demands Cannabis Advocates Cover Legal Costs (High Times)

• Banking Activity Increases In States That Legalize Marijuana, Study Finds (Marijuana Moment)

• Cannabis Companies Target Teens on Social Media, Study Claims (High Times)

• Cloudastructure’s Artificial Intelligence is Revolutionizing Cannabis Surveillance (High Times)

Magic Mushrooms

• Controversial Kansas Lawmaker Files Bill To Legalize Psilocybin Possession And Cultivation (Marijuana Moment)

• Bipartisan Congressional Lawmakers Tell DEA To Allow Psilocybin Treatment For Terminal Patients (Marijuana Moment)

• New Research Probes Psilocybin’s Effect on Suicidality (Lucid News)

• Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent (Psilocybin Alpha)

MDMA

• Why MDMA Makes You Horny (VICE)

• Use of ecstasy and cocaine drops during pandemic (Irish Examiner)

• Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical Trial (Psilocybin Alpha)

• The MDMA Comedown: Why Coming Down From Molly Feels So Bad (DoubleBlind)

• A psychedelic trip to recovery: How psychedelics can help treat PTSD (The Ubyssey)

DMT

• Algernon Pharmaceuticals Files for Clinical Trial and Ethics Approval for Phase 1 DMT Human Stroke Study (Psilocybin Alpha)

• Why Do People See Elves And Other "Entities" When They Smoke DMT? (IFLScience)

Ayahuasca

• Do Ayahuasca Healing Ceremonies Really Work? (Psychology Today)

Morning Glory Seeds

• What Is LSA? Your Guide To The Complicated Psychedelic (Healing Maps)

Novel Psychoactive Substances

• BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001 (Psilocybin Alpha)

Synthetic Cannabinoids

• Study: Cannabinoids May Help Prevent and Treat Peanut Allergies (The Marijuana Herald)

• Trial Will Test Synthetic Cannabinoid for Weight Loss in Obesity (Medscape)

• Dyadic Introduces Novel Method to Produce Synthetic Cannabinoids and Precursors Utilizing C1 Cell Line Production Platform and Patent Pending Process (GlobeNewswire)

Ketamine

• Plastic Surgeons Are Using Ketamine to Make Nose Jobs More Pleasant (Allure)

Datura

• Are your food grains adulterated with poisonous dhatura (Times of India)

Miscellaneous

• DEA Proposes Adding 5 More Psychedelics to Schedule 1 Controlled Substances (Psychedelic Spotlight)

• Psychedelic use is only “weakly” associated with psychosis-like symptoms, according to new research (PsyPost)

• Utah Lawmaker Files Bill To Explore Therapeutic Use of Psychedelics (High Times)

• Psychedelics ‘Train Has Left the Station’ Says Federal Drug Official as More States Seek Access (Psychedelic Spotlight)

• Sydney Researchers Awarded Over $2.2 Million By Australian Government To Study MDMA, Psilocybin (Forbes)

• Missouri Lawmaker Files Bill To Decriminalize Low-Level Drug Possession (Marijuana Moment)

• Psychedelic legalization now (The New Amsterdam Psychedelic Law Blog)

• Psygen Receives Dealer’s Licence To Become Canada’s First Dedicated Psychedelics Manufacturing Facility (The Dales Report)

• Allowing psychedelic assisted therapy is an enlightened move, medical experts say (National Post)

• Majority of Mental Health Patients Support Access to Psychedelics, Survey Finds (Psychedelic Spotlight)

• Psychedelic Company Highlights in 2021 (Psilocybin Alpha)

• Talking Drugs Updates from Eastern Europe and Central Asia (TalkingDrugs)

• Pandemic Tripping With Psychedelics (Green Market Report)

• What are the potential risks of microdosing psychedelics? (Leafly)

• Cybin Set to Measure Psychedelic Effects on the Brain Using Kernel Flow’s Revolutionary Technology (Psychedelic Spotlight)

• Peek Inside Philadelphia’s Psychedelics Revolution (Philadelphia Magazine)

• Psychedelic Science Leader Eleusis to Become Public Company in Merger with Silver Spike Acquisition Corp. II (Psilocybin Alpha)

• How Port Townsend, Washington, Decriminalized Psychedelics (Filter)

• Athletes and Psychedelics: Mental Health and Performance (Truffle Report)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.14.22

Cannabis

• Oregon State research shows hemp compounds prevent coronavirus from entering human cells (Oregon State University)

• Polls Funded By Marijuana Prohibitionist Group Show Big Support For Legalization Policies It Lobbies Against (Marijuana Moment)

• Top German Government Official Previews Marijuana Legalization Plan Details (Marijuana Moment)

• First-dose vaccinations quadruple in Quebec ahead of restrictions at liquor and cannabis stores (CTV News)

• Mississippi Senate Votes To Legalize Medical Marijuana, Defying Governor’s Veto Threat (Marijuana Moment)

• Oregon: New Rules Increase the Amount of Cannabis Adults Can Purchase Per Transaction (NORML)

• Ohio Marijuana Activists Turn In More Signatures For Legalization Initiative After Temporary Setback (Marijuana Moment)

• Delaware Lawmakers File New Marijuana Legalization Bill With Key Equity Revisions (Marijuana Moment)

• Kansas lawmaker wants to refer medical marijuana legalization to voters (Marijuana Business Daily)

• Austin Officials Certify Local Marijuana Decriminalization Initiative For May Ballot (Marijuana Moment)

• Wyoming Activists Prepare Cannabis Reform Initiatives (High Times)

• Virginia Lawmakers Divided On Releasing Marijuana Prisoners Following Legalization Taking Effect (Marijuana Moment)

• South Dakota Governor Wants Marijuana Activists To Pay Legal Bill For Her Lawsuit That Blocked Legalization (Marijuana Moment)

• Florida Marijuana Activists Pivot To 2024 For Legalization Ballot Initiative (Marijuana Moment)

Magic Mushrooms

• Global Coalition Launches Push To Reschedule Psilocybin Under International Rules (Marijuana Moment)

• Italian Officials Certify Signatures For National Marijuana And Psilocybin Referendum (Marijuana Moment)

• Rollups: The Emerging Magic Mushroom Monopoly (The American Prospect)

• Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product (Psilocybin Alpha)

• Psilocybin Clinical Trial for Depression Launches at Pacific Neuroscience Institute (PR Newswire)

MDMA

• MAPS Publishes Open Science Approach to Synthesizing MDMA (Lucid News)

Ayahuasca

• A New Study Attempts To Quantify The Healing Powers Of Ayahuasca (Forbes)

Novel Psychoactive Substances

• Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development Enabling Quick Screening of Billions of Compounds (Psilocybin Alpha)

• Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development (Psilocybin Alpha)

Ketamine

• Trial of Ketamine Therapy for Alcohol Use Disorder Reports Positive Findings (Technology Networks)

• Osmind Announces Publication of the Largest Real-World Analysis of Ketamine Infusion Therapy for Depression (Business Wire)

• Institutional Review Board Grants Approval for Cybin-Sponsored Feasibility Study Using Kernel Flow Technology to Measure Psychedelic Effects on the Brain (Psilocybin Alpha)

• Peter Thiel-Backed Psychedelics Company Gets FDA Approval To Study Ketamine Therapy (Forbes)

• PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS (Psilocybin Alpha)

Miscellaneous

• How Beer and Drugs Empowered an Ancient Andean Empire (Gizmodo)

• These States Could Legalize Marijuana Or Psychedelics In 2022 (Marijuana Moment)

• Virginia Could Decriminalize Psilocybin And Other Psychedelics With Newly Filed Bills (Marijuana Moment)

• Social Media Attacks and Ethical Issues in the Psychedelic Sector — Why can’t we all get on together for the greater good? (Medium)

• Missouri Patients Could Use Psychedelic Treatments Under New GOP ‘Right-To-Try’ Bill (Marijuana Moment)

• ‘Microdosers’ of LSD and magic mushrooms are wiser and more creative (Daily Maverick)

• Promising Psychedelic Therapy Legislation Set to Make Waves in 2022 (Psychedelic Spotlight)

• Vermont Lawmakers File Drug Decriminalization Bill With Hopes Of Promoting Harm Reduction (Marijuana Moment)

• Announcing a Major Healthy Persons Trial to Investigate the Brain Activity Effects of Psychedelic Medicines (Mind Medicine Australia)

• University Of Ottawa To Offer Psychedelic Studies Master’s Program Beginning In Fall 2022 (Healing Maps)

• The Connection between Psychedelics and Christianity (The Institute for the Advancement of Psychedelic Christianity)

• Metaphysical Insight: Psychedelics, Noetic Experiences, and Spinoza’s God (Sam Woolfe)

• How to Come Out to Your Kids About Psychedelics (DoubleBlind)

• Psychedelics in Healthcare: The Psychedelic Pharmacists Association (Truffle Report)

• Can Western Medicine Include the Sacred in Psychedelic-Assisted Psychotherapy? (Lucid News)

• How To Vet Your Psychedelic Guide (DoubleBlind)

• Mydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted Psychotherapy For Patients (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.7.22

Cannabis

• Sadiq Khan plans pilot to ‘decriminalise’ minor cannabis offences in London (The Guardian)

• Legal recreational marijuana sales begin in Montana (KPAX)

• Federal Marijuana Monopoly Finally Ends As Two Companies Harvest Cannabis Approved By DEA (Marijuana Moment)

• New year rings in key changes to state marijuana markets (Marijuana Business Daily)

• GOP-Controlled New Hampshire House Votes To Legalize Marijuana Possession And Cultivation (Marijuana Moment)

• Colorado: Governor Issues Pardons to Over 1,300 Marijuana Offenders (NORML)

• Wyoming Marijuana Activists Turn Focus To 2024 Ballot For Decriminalization And Medical Cannabis Initiatives (Marijuana Moment)

• The top cannabis research studies of 2021 (Leafly)

• Incoming Virginia GOP Governor Won’t ‘Overturn’ Legal Marijuana Possession, But Casts Doubt On Sales (Marijuana Moment)

• Top Kansas Democrats Unveil Plan To Put Medical And Adult-Use Marijuana Legalization On The 2022 Ballot (Marijuana Moment)

• Two recreational marijuana initiatives might appear on Oklahoma ballot in fall (Marijuana Business Daily)

• Iowa Democrats Unveil Marijuana Resolution To Put Legalization On Ballot For Voters To Decide (Marijuana Moment)

• New Republican-Led Bill Would Legalize Medical Cannabis In Kentucky (Marijuana Moment)

• South Dakota Lawmakers Prepare Dozens Of Cannabis Reform Bills (High Times)

• Marijuana Decriminalization Reduces Arrests And Racial Disparities In Law Enforcement, Study Finds (Marijuana Moment)

• Tiny but mighty: Micro-cultivators dominated 2021 (Leafly)

• The cost of medical marijuana in Louisiana (KSLA)

• Israeli startup a go-to resource in medical cannabis world (I24News)

• Oklahoma Pot Farm Slapped with RICO From Next Door Neighbor (High Times)

• Cannabis users report higher quality of life than non-users (Leafie)

Magic Mushrooms

• Washington Psilocybin Bill Would Legalize Supported Adult Use (Bill of Health)

• COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology (Psilocybin Alpha)

• New Hampshire Bipartisan Bills Want to Reduce Penalties on Psilocybin, Other Drugs (Truffle Report)

• Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge Eating Disorder (Psilocybin Alpha)

• Filament Health Announces Health Canada Approval for Phase II Trial Administering New Psilocybin Microdose Formulation (Psilocybin Alpha)

• Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete Second Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

• Psilocybin therapy options could expand in Hawaiʻi (Hawai'i Public Radio)

MDMA

• Drug testing: Dramatic drop in bath salts being sold as MDMA (Radio New Zealand)

• Microdosing MDMA: What Research Says About Doing It For Mental Health Issues (Healing Maps)

DMT

• Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory Submission to Ethics Committee (Psilocybin Alpha)

Ayahuasca

• IRS defends denial of Des Moines church's tax-free status over use of psychedelic drug (KCCI)

• Anti-Drug GOP Senator Helps Psychedelic Church With Fight Against DEA And IRS (Marijuana Moment)

Iboga

• National Institute on Drug Abuse to Test Ibogaine For Addiction Treatment (Truffle Report)

• Caribbean Facility Finds Consistent Success Using Ibogaine for Anxiety and Trauma Treatment (PR Newswire)

Novel Psychoactive Substances

• MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC (Psilocybin Alpha)

• Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic Compounds (Psychedelic Spotlight)

Synthetic Cannabinoids

• Using cannabinoids to treat obesity (Medical Xpress)

• More needs to be done to tackle synthetic cannabinoids, experts say (Stuff.co.nz)

Ketamine

• Awakn Life Sciences Expands World's First Ketamine Study Beyond Gambling Disorder to Include Additional Behavioral Addictions (Yahoo!)

• PharmaTher Announces Publication of Research Data for KETABET™ (Psilocybin Alpha)

Miscellaneous

• The Promises and Perils of Psychedelic Health Care (The New York Times)

• Health Canada Grants Special Access to Restricted Drugs for Psychedelic Therapy (Psychedelic Spotlight)

• Magic mushroom companies are on the Nasdaq now. That’s a recipe for a bad trip (The Guardian)

• Psychedelics Can Change Your View on the Nature of Reality (Psychedelic Spotlight)

• Psychedelics in 2022: What to Expect (Truffle Report)

• Fact Check-London Mayor not decriminalising drugs (Reuters)

• Psychedelics 2021: A Year in Review (Psilocybin Alpha)

• Will overdose deaths force an end to the US ‘war on drugs’? (Financial Times)

• Philippines' Duterte says will never apologise for drug war deaths (Reuters)

• New York Prisons Punished 1,600 People for False Drug Test Results (Filter)

• Now psychedelics are coming to your medicine cabinet (ISRAEL21c)

• How Psychedelic Therapy Fuses Indigenous Shamanism With Western Science (IFLScience)

• Pop Culture Boosts Acceptance of Plant Medicine (GlobeNewswire)

• Can A Psychedelic Experience Improve 2022? (Reality Sandwich)

• Psychedelic Drug Policy Reform in 2021: A Year in Review (Psilocybin Alpha)

• Psychedelics Will Have a Big Presence at SXSW in 2022 (Psychedelic Spotlight)

• Was 2021 the Year Psychedelics Conquered Capitalism? (Green Entrepreneur)

• Startup To Host Psychedelic Trips In The Metaverse (Forbes)

• Is ‘The Trip’ Essential to The Psychedelic Experience? (Psychedelic Spotlight)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 12.31.21

Cannabis

• Germany Moves To Legalize Cannabis, Second Country After Malta In Europe (Forbes)

• New Marijuana Laws Take Effect Across The U.S. With The New Year (Marijuana Moment)

• Cannabis in ’22: Is federal legalization on the horizon? (Profiles in Legalization)

• These European Countries Could Legalize Cannabis In 2022 (Forbes)

• New Mexico County Prepares for Recreational Cannabis (U.S. News and World Report)

• New Hampshire Lawmakers File Multiple Marijuana Legalization Bills Ahead Of 2022 Session (Marijuana Moment)

• Indiana Marijuana Legalization And Regulatory Bills Pre-Filed For 2022 Session (Marijuana Moment)

• 2021 Roundup of Cannabis Reform in Europe (and 2022 Predictions) (High Times)

• Cannabis Company Says Afghanistan Plans Hinge On International Recognition Of Taliban Regime (Marijuana Moment)

• Cannabis Testing Prohibited for Most Philadelphia Job Applicants Starting 2022 (High Times)

• How Decriminalization Impacts Racial Disparities in Cannabis Arrests (Filter)

• New Mexico Releases Final Adult-Use Cannabis Rules (High Times)

• Wisconsin Governor Grants Marijuana And Drug-Related Pardons, Setting State Clemency Record (Marijuana Moment)

• Rochester, New York Mayor-Elect Plans Guaranteed Basic Income From Cannabis Taxes (High Times)

• One-Third Of Programmers Use Marijuana While Working, With Many Touting Creative Benefits, Study Finds (Marijuana Moment)

• Australia Cannabis Legalization Support Has Doubled in Six Years (High Times)

• Mississippi Governor Won’t Sign Medical Cannabis Bill Without Major Changes (High Times)

LSD

• When Trey Parker and Matt Stone went to the Oscars on LSD (Far Out Magazine)

Magic Mushrooms

• New Hampshire Lawmakers File Psilocybin And Broader Drug Decriminalization Bills For 2022 (Marijuana Moment)

• Brain Damage From Alcohol May Be Reversed By Using Magic Mushrooms, Per Study (Healing Maps)

• Depression and Grief Wrecked a Man's Life—Until He Took Magic Mushroom Ingredient (Newsweek)

• COMPASS Patent Challenge Targets Crystallography Errors (Psychedelic Science Review)

MDMA

• Warning over high-dose MDMA circulating in Sydney (9News)

Ayahuasca

• Iowa Church Using Hallucinogen During Services Denied Tax-Exempt Status (Newsweek)

Synthetic Cannabinoids

• Children collapse in school after vaping £10 fake cannabis oil laced with Spice ‘sold on Snapchat’ (The Sun)

Nitrous Oxide

• Business offers to deliver dangerous nitrous oxide nangs to your home (Australian Broadcasting Corporation)

Ketamine

• Ketamine Therapy Is Going Mainstream. Are We Ready? (The New Yorker)

• I Took Ketamine for My Depression. Things Got Pretty Weird. (The New York Times)

Miscellaneous

• Drug testing at festivals becomes legal at New Year (New Zealand Herald)

• Feds Announce Funds For Drug Harm Reduction Studies, Including On Decriminalization And Safe Consumption Sites (Marijuana Moment)

• Looking Back at 2021’s Psychedelics Milestones (Truffle Report)

• National Group Submits Colorado Psychedelics Decriminalization Ballot Measures (High Times)

• Here Are The Biggest Marijuana, Psychedelics And Drug Policy News Stories Of 2021 (Marijuana Moment)

• Highlights from a landmark year in psychedelic science (New Atlas)

• How AI Could Prevent the Development of New Illicit Drugs (Undark)

• It’s Been A Banner Year For MAPS Public Benefit Corporation And The Women Leading It (Forbes)

• 2021: A Year in Review for the Psychedelics Business (Psychedelic Spotlight)

• SXSW Selects Multiple Marijuana And Psychedelics Panels For 2022 Festival (Marijuana Moment)

• The Psychedelic Drugs Market to Be Defined By Exceptional Digitization (Lake Shore Gazette)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 12.24.21

Cannabis

• Analysis: Unregulated Delta-8 Vape Products Frequently Mislabeled, May Contain Heavy Metals (NORML)

• Malta Officially Legalizes Marijuana With President’s Signature, Becoming First In Europe To End Cannabis Prohibition (Marijuana Moment)

• Several States to Usher In the New Year with Cannabis Liberalization Laws (NORML)

• The Next States to Legalize Recreational Marijuana (MSN)

• Pfizer Bets On Medical Cannabis With $6.7 Billion Acquisition (Forbes)

• Scientists are (finally) studying how weed affects athletic performance and recovery (Leafly)

• New York Senator Files Bill To Extend Marijuana Equity Benefits To Gay, Lesbian And Bisexual People (Marijuana Moment)

• Cartels Ditch Pot and Opium Fields for Synthetic Drugs, Mexico Defense Secretary Says (High Times)

• Ohio: Citizens’ Petition Seeks to Compel Lawmakers to Hold Marijuana Legalization Vote (NORML)

• Senator Calls For Federal Marijuana Standard To Measure Impaired Driving (Marijuana Moment)

• Top Maryland Lawmaker Files Marijuana Legalization Referendum For 2022 Ballot (Marijuana Moment)

• Iowa Democrats Announce Plan To Let Voters Decide On Marijuana Legalization Amid GOP Resistance (Marijuana Moment)

• Whole-Plant Cannabis Extract Reduces Epileptic Seizures By 86% in Small Study (High Times)

• Researcher Uses Reddit To Learn What Kinds Of Marijuana Posts Influenced Legalization Attitudes (Marijuana Moment)

• Pair of Cops Booked After Being Caught Smoking Pot in Mississippi (High Times)

• Marijuana Group Releases ‘Robbery Preparedness Guide’ For Dispensaries Amid Spike In Thefts (Marijuana Moment)

• Dr. Sanjay Gupta adds to chorus of cannabis research on autism in 2021 (Leafly)

• Legal Cannabis Outsells Ontario Illicit Market for First Time (High Times)

• These were the weirdest weed news stories of 2021 (Leafly)

LSD

• U.S. FDA puts plans to test LSD in anxiety patients in clinical study on hold (Reuters)

Magic Mushrooms

• Canada’s Psilocybin Policy Reform Movement Continues to Make Progress Federally (Truffle Report)

• FDA Approves Psilocybin For Binge Eating Study By Tryp Therapeutics (Benzinga)

Ayahuasca

• Global ayahuasca trend drives deforestation in Brazil’s Acre state (Mongabay)

Morning Glory Seeds

• Study shows common flower species holds promise for beneficial psychedelic drugs (Newswise)

Ketamine

• Ketamine Therapy Quickly Reduces Depression and Suicidal Thoughts (SciTechDaily)

DXM

• Cough medicine creates dangerous interaction (The Seattle Times)

Miscellaneous

• Port Townsend Becomes 13th City to Decriminalize Psychedelics (DoubleBlind)

• Psychedelics: The newest tool in nuclear negotiations? (Bulletin of the Atomic Scientists)

• How Should Psychedelic Medicine Handle “Flashbacks”? (Mad in America)

• New center to study psychedelics pops up at University of Texas at Austin (My San Antonio)

• The Dumbest Drug Scare Stories of 2021 (VICE)

• DEA Wants To Help Parents Decode The Emojis Young People Use To Discuss Marijuana And Other ‘Bomb Ass’ Drugs (Marijuana Moment)

• GOP Lawmakers File Bills To Streamline Research Into Marijuana, Psychedelics And Other Schedule I Drugs (Marijuana Moment)

• Colorado Ballot Initiatives Filed to Legalize Psychedelics (Truffle Report)

• Two Leaders in Psychedelics Industry and the Harm Reduction Approach (Nasdaq)

• How Do Hallucinogenic Drugs Change Our Personality? (Psychology Today)

• Microdosing companion app Houston wants to be your guide to 'inner space' (Mashable)

• Why Psychedelic Research May Bring the Next Big Breakthrough in Dementia Treatment (Psychedelic Spotlight)

• MYND Life Sciences Acquires Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and other Dementias (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.